So-Called “Puppy Mills” Are Not All As Bad As We Think, Pioneering Research Suggests

So-Called “Puppy Mills” Are Not All As Bad As We Think, Pioneering Research Suggests

New research challenges the popular notion that all commercial breeding kennels are inhumane.

(© sommai/Adobe Stock)


Keep Reading Keep Reading
Kim Kavin
Kim Kavin is a lifelong journalist who has been reporting on and writing about the dog industry for nearly a decade. Her 2012 book Little Boy Blue and her 2016 book The Dog Merchants both won national awards. More recently, Kim won the 2019 Donald Robinson Prize for Investigative Journalism for a piece in The Washington Post that documented a multimillion-dollar river of cash flowing from rescue nonprofits, shelters and dog-advocacy groups through dog auctions into the pockets of dog breeders. Kim lives in New Jersey with her two adopted shelter mutts. Learn more about her at www.kimkavin.com
A new type of cancer therapy is shrinking deadly brain tumors with just one treatment

MRI scans after a new kind of immunotherapy for brain cancer show remarkable progress in one patient just days after the first treatment.

Mass General Hospital

Few cancers are deadlier than glioblastomas—aggressive and lethal tumors that originate in the brain or spinal cord. Five years after diagnosis, less than five percent of glioblastoma patients are still alive—and more often, glioblastoma patients live just 14 months on average after receiving a diagnosis.

But an ongoing clinical trial at Mass General Cancer Center is giving new hope to glioblastoma patients and their families. The trial, called INCIPIENT, is meant to evaluate the effects of a special type of immune cell, called CAR-T cells, on patients with recurrent glioblastoma.

Keep Reading Keep Reading
Sarah Watts

Sarah Watts is a health and science writer based in Chicago.

Artificial Intelligence is getting better than humans at detecting breast cancer

A recent study in The Lancet Oncology showed that AI found 20 percent more cancers on mammogram screens than radiologists alone.

The Lancet Oncology

Since the early 2000s, AI systems have eliminated more than 1.7 million jobs, and that number will only increase as AI improves. Some research estimates that by 2025, AI will eliminate more than 85 million jobs.

But for all the talk about job security, AI is also proving to be a powerful tool in healthcare—specifically, cancer detection. One recently published study has shown that, remarkably, artificial intelligence was able to detect 20 percent more cancers in imaging scans than radiologists alone.

Keep Reading Keep Reading
Sarah Watts

Sarah Watts is a health and science writer based in Chicago.